FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 1 through 27 of 27

- SIC # 2840

Ticker Exchange Company Financial Reports SIC #
BCPC Nasdaq Balchem Corporation 2840
BHC New York Bausch Health Companies Inc. 2840
CDXC Nasdaq ChromaDex Corporation 2840
CHDRY Over the counter Christian Dior SE 2840
COTY New York Coty Inc. 2840
CPHI NYSE American China Pharma Holdings, Inc. 2840
DARE Nasdaq Daré Bioscience, Inc. 2840
DSY Nasdaq Big Tree Cloud Holdings Limited 2840
ELAB Nasdaq PMGC Holdings Inc. 2840
EPC New York Edgewell Personal Care Company 2840
FBIO Nasdaq Fortress Biotech, Inc. 2840
FEBO Nasdaq Fenbo Holdings Limited 2840
FTLF Nasdaq FitLife Brands, Inc. 2840
IBO NYSE American Impact BioMedical Inc. 2840
NXGL Nasdaq NEXGEL, Inc. 2840
OGN New York Organon & Co. 2840
PAVS Nasdaq Paranovus Entertainment Technology Ltd. 2840
PBH New York Prestige Consumer Healthcare Inc. 2840
PRGO New York Perrigo Company plc 2840
SKIN Nasdaq The Beauty Health Company 2840
TRUMY Over the counter Terumo Corporation 2840
TXMD Nasdaq TherapeuticsMD, Inc. 2840
UPXI Nasdaq Upexi, Inc. 2840
USNA New York USANA Health Sciences, Inc. 2840
VERU Nasdaq Veru Inc. 2840
WALD Nasdaq Waldencast plc 2840
ZIVO Over the counter ZIVO Bioscience, Inc. 2840
Results 0 through 27 of 27